About Cytosurge
Cytosurge is a company based in Zurich (Switzerland) founded in 2009 by Michael Gabi and Pascal Behr. It operates as a B2B and D2C. Cytosurge offers products and services including FluidFM OMNIUM Platform, CellEDIT Service, and Online Quoter. Cytosurge operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Zurich, Switzerland
- Founders Michael Gabi, Pascal Behr
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cytosurge Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cytosurge
Cytosurge offers a comprehensive portfolio of products and services, including FluidFM OMNIUM Platform, CellEDIT Service, and Online Quoter.
Platform for single-cell manipulation and biopsies
Service for CRISPR cell line engineering and knockouts
Tool for quoting cell editing services online
People of Cytosurge
Unlock access to complete
Funding Insights of Cytosurge
Detailed funding history for Cytosurge
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cytosurge
Investment portfolio details for Cytosurge
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cytosurge
Detailed financials for Cytosurge
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cytosurge Comparisons
Peer comparison for Cytosurge
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cytosurge
Cytosurge operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Cytosurge
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cytosurge
Complete news archive for Cytosurge
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytosurge
Cytosurge was founded in 2009.
Cytosurge is headquartered in Zurich, Switzerland.
Pascal Behr is the current CEO of Cytosurge. They have also founded this company.
Cytosurge AG specializes in developing and providing FluidFM technology for precise single-cell injection, extraction, and biopsies in life sciences. The company offers products like the FluidFM OMNIUM Platform and services such as CellEDIT for CRISPR-based cell line engineering. Based in Switzerland, it serves researchers and institutions by bridging genetic design tools with practical applications, focusing on synthetic biology and therapy manufacturing.
Cytosurge's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Cytosurge offers FluidFM OMNIUM Platform, CellEDIT Service, and Online Quoter.